[Efficacy of levofloxacin 500 mg for middle ear diseases].

Takashi Kimitsuki, Takamasa Yoshida, Shizuo Komune

研究成果: Contribution to journalArticle査読

抄録

We examined the cases that prescribed levofloxacin (LVFX) 500mg for middle ear diseases in our hospital. LVFX 500mg was prescribed in 18 cases (7 male, 11 female, 24-81 years old). LVFX was mainly used for the following clinical conditions, 1) otitis media with granulation proliferation: 3 cases, 2) infection to an artificial materials : 5 cases, 3) treatment for or prevention against the inflammation of the inner ear: 4 cases. Three of eighteen cases were ineffective by LVFX treatment. Bacteriological examination indicated LVFX-resistant MRSA or Pseudomonas aeruginosa were isolated in these three cases.

本文言語英語
ページ(範囲)43-48
ページ数6
ジャーナルFukuoka igaku zasshi = Hukuoka acta medica
103
2
出版ステータス出版済み - 2 2012

All Science Journal Classification (ASJC) codes

  • Medicine(all)

フィンガープリント 「[Efficacy of levofloxacin 500 mg for middle ear diseases].」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル